Brind.

Guardant Health announced AmirAli Talasaz as Co-CEO, alongside reports of volume growth and gross margin turnaround.

3 reports, 1 independent Updated Aug 13

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Guardant Health announced AmirAli Talasaz as Co-CEO, alongside reports of volume growth and gross margin turnaround.

Who's involved

What this event is mainly about

Guardant Health

Keep exploring

The entities involved

Guardant Health
American biotechnology company
- Scott Bessent's call for a rate cut fuels a risk-on environment for companies like agilon health.Sun 05:03
- EVANS welcomed Guardant Health as a sponsor for a coalition planning events across North America.Sat 21:20

Coverage

Newest first; wire copies grouped

Aug 13StockStoryThe 5 Most Interesting Analyst Questions From Guardant Health’s Q2 Earnings Call Guardant Health’s second quarter results reflected robust demand across its core oncology and screening businesses, ye
Aug 13StockStoryGH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges Diagnostics company Guardant Health (NASDAQ:GH) announced better-than-expected revenue in Q2 CY2025, with sal
Jun 25Unknown outlet